| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,493 |
5,711 |
$355K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,995 |
6,400 |
$283K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,017 |
2,348 |
$38K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
325 |
297 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
245 |
221 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
371 |
323 |
$14K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,011 |
901 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
59 |
57 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
324 |
151 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,269 |
2,113 |
$3K |
| 81002 |
|
1,980 |
1,807 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
611 |
442 |
$2K |
| 90674 |
|
65 |
54 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
57 |
50 |
$649.39 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
54 |
42 |
$545.85 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$97.33 |
| 94760 |
|
53 |
42 |
$53.00 |
| 3008F |
|
53 |
46 |
$0.00 |